diagnosis

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis

Understanding MOG Antibody-Associated Disease MOG antibody-associated disease (MOGAD) is increasingly recognized as a unique demyelinating condition in the pediatric population, […]

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis Read Post »

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis

Clinical Features of MOGAD in Pediatrics MOG-antibody associated disease (MOGAD) presents with a spectrum of symptoms that can vary widely

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis Read Post »

Mortality in Castration Resistant Prostate Cancer Patients With and Without Pre-Existing Cardiovascular Disease Receiving Oral Androgen Receptor Pathway Inhibitors

Study Overview The relationship between cardiovascular health and prostate cancer outcomes has garnered attention due to the shared risk factors

Mortality in Castration Resistant Prostate Cancer Patients With and Without Pre-Existing Cardiovascular Disease Receiving Oral Androgen Receptor Pathway Inhibitors Read Post »

Neuropsychological criteria for Mild Cognitive Impairment (MCI) best identify neuroimaging-based risk profiles: A Department of Defense/Alzheimer’s Disease Neuroimaging Initiative study

Neuropsychological Criteria Overview The evaluation of Mild Cognitive Impairment (MCI) through neuropsychological criteria plays a crucial role in identifying individuals

Neuropsychological criteria for Mild Cognitive Impairment (MCI) best identify neuroimaging-based risk profiles: A Department of Defense/Alzheimer’s Disease Neuroimaging Initiative study Read Post »

Scroll to Top